Shantanu De

Title: Shantanu De: Innovator in Pharmaceutical Chemistry

Introduction

Shantanu De is a prominent inventor based in New Delhi, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative processes for drug preparation. With a total of 2 patents to his name, he has established himself as a key figure in the industry.

Latest Patents

Shantanu De's latest patents include a process for the preparation of rosuvastatin and a process for the preparation of benazepril. The rosuvastatin patent relates to a process for the preparation of rosuvastatin calcium, which is recognized as a promising new HMG-CoA reductase inhibitor. The benazepril patent describes an improved process for the preparation of trifluoromethanesulfonic ester of ethyl (R)-2-hydroxy-4-phenylbutyrate, which serves as an intermediate for the preparation of the ACE inhibitor, benazepril.

Career Highlights

Shantanu De is currently associated with Ranbaxy Laboratories, Inc., where he continues to innovate and contribute to the pharmaceutical sector. His work has been instrumental in advancing drug formulations and improving therapeutic outcomes for patients.

Collaborations

Shantanu has collaborated with notable colleagues such as Yatendra Kumar and Hashim Nizar Poovanathil Nagoor Meeran. These collaborations have further enhanced his research and development efforts in the pharmaceutical field.

Conclusion

Shantanu De's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his importance in the industry. His work continues to pave the way for advancements in drug development and therapeutic solutions.